Monkeypox antiviral drug put to the test in trial
Researchers hope the drug – tecovirimat – can help accelerate patient recovery from the virus. …
Tecovirimat – also known as Tpoxx – prevents the virus from leaving infected cells, stopping its spread within the body. It was licensed earlier this year for monkeypox, based on promising results from initial studies in animals and evidence of safety in healthy human volunteers.
About The Author
